PLT012
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PLT012, covering 2026-02-18 to 2026-02-18. Get the full timeline:
Most recent: Clinical Trial Update: A First in Human Study of PLT012 in Participants With Solid Tumor Cancers [Phase 1]